Two rare CHST3 missense variants, p.(Cys247Ser) and p.(Leu294Pro), in the homozygous and compound-heterozygous state cause chondrodysplasia with congenital joint dislocations in a consanguineous Syrian kindred
References
- Geister, K.A. and S.A. Camper, Advances in Skeletal Dysplasia Genetics. Annu Rev Genomics Hum Genet, 2015. 16: 199–227.
- Krakow, D. and D.L. Rimoin, The skeletal dysplasias. Genet Med, 2010. 12(6): 327–41.
- Mortier, G.R., et al., Nosology and classification of genetic skeletal disorders: 2019 revision. Am J Med Genet A, 2019. 179(12): 2393–2419.
- Unger, S., et al., Nosology of genetic skeletal disorders: 2023 revision. Am J Med Genet A, 2023. 191(5): 1164–1209.
- Mizumoto, S. and S. Yamada, Congenital Disorders of Deficiency in Glycosaminoglycan Biosynthesis. Front Genet, 2021. 12: 717535.
- Begolli, G., et al., Carbohydrate sulfotransferases: a review of emerging diagnostic and prognostic applications. Biochem Med (Zagreb), 2023. 33(3): 030503.
- Fukuta, M., et al., Molecular cloning and expression of human chondroitin 6-sulfotransferase. Biochim Biophys Acta, 1998. 1399(1): 57–61.
- Negishi, M., et al., Structure and function of sulfotransferases. Arch Biochem Biophys, 2001. 390(2): 149–57.
- Uchimura, K., et al., Functional analysis of the chondroitin 6-sulfotransferase gene in relation to lymphocyte subpopulations, brain development, and oversulfated chondroitin sulfates. J Biol Chem, 2002. 277(2): 1443–50.
- Rajab, A., J. Kunze, and S. Mundlos, Spondyloepiphyseal dysplasia Omani type: a new recessive type of SED with progressive spinal involvement. Am J Med Genet A, 2004. 126A(4): 413–9.
- Thiele, H., et al., Loss of chondroitin 6-O-sulfotransferase-1 function results in severe human chondrodysplasia with progressive spinal involvement. Proc Natl Acad Sci U S A, 2004. 101(27): 10155–60.
- Hermanns, P., et al., Congenital joint dislocations caused by carbohydrate sulfotransferase 3 deficiency in recessive Larsen syndrome and humero-spinal dysostosis. Am J Hum Genet, 2008. 82(6): 1368–74.
- van Roij, M.H., et al., Spondyloepiphyseal dysplasia, Omani type: further definition of the phenotype. Am J Med Genet A, 2008. 146A(18): 2376–84.
- Tuysuz, B., et al., Omani-type spondyloepiphyseal dysplasia with cardiac involvement caused by a missense mutation in CHST3. Clin Genet, 2009. 75(4): 375–83.
- Unger, S., et al., Phenotypic features of carbohydrate sulfotransferase 3 (CHST3) deficiency in 24 patients: congenital dislocations and vertebral changes as principal diagnostic features. Am J Med Genet A, 2010. 152A(10): 2543–9.
- Superti-Furga, A. and S. Unger, Chondrodysplasia with Congenital Joint Dislocations, CHST3-Related, in GeneReviews((R)), M.P. Adam, et al., Editors. 1993: Seattle (WA).
- Otaify, G.A., et al., CHST3-related skeletal dysplasia in 14 patients: Identification of 8 novel variants and further expansion of the phenotypic spectrum. Am J Med Genet A, 2023. 191(8): 2100–2112.
- Singh, S., et al., Indian patients with CHST3-related chondrodysplasia with congenital joint dislocations. Am J Med Genet A, 2024. 194(3): e63422.
- Waryah, A.M., et al., A novel CHST3 allele associated with spondyloepiphyseal dysplasia and hearing loss in Pakistani kindred. Clin Genet, 2016. 90(1): 90–5.
- Srivastava, P., et al., Spondyloepiphyseal dysplasia Omani type: CHST3 mutation spectrum and phenotypes in three Indian families. Am J Med Genet A, 2017. 173(1): 163–168.
- Kausar, M., et al., Biallelic variants in CHST3 cause Spondyloepiphyseal dysplasia with joint dislocations in three Pakistani kindreds. BMC Musculoskelet Disord, 2022. 23(1): 818.
- Mughal, T.A., et al., A Novel Missense Variant in the CHST3 Underlies Spondyloepiphyseal Dysplasia with Congenital Joint Dislocations. Mol Syndromol, 2024. 15(5): 355–361.
- Pantoja-Melendez, C.A., et al., Epidemiological and Molecular Characterization of a Mexican Population Isolate with High Prevalence of Limb-Girdle Muscular Dystrophy Type 2A Due to a Novel Calpain-3 Mutation. PLoS One, 2017. 12(1): e0170280.
- Duz, M.B. and A. Topak, Recurrent c.776T>C mutation in CHST3 with four other novel mutations and a literature review. Clin Dysmorphol, 2020. 29(4): 167–172.
- Hackl, L., et al., Homozygous DHCR7 p.Val330Met Variant Associated with Mild Non-Syndromic Intellectual Disability and Elevated Serum 7-Dehydrocholesterol Levels in Two Siblings. Genes (Basel), 2025. 16(7).
- Gudmundsson, S., et al., Variant interpretation using population databases: Lessons from gnomAD. Hum Mutat, 2022. 43(8): 1012–1030.
- Ioannidis, N.M., et al., REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants. Am J Hum Genet, 2016. 99(4): 877–885.
- Rentzsch, P., et al., CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res, 2019. 47(D1): D886–D894.
- Pejaver, V., et al., Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria. Am J Hum Genet, 2022. 109(12): 2163–2177.
- Jumper, J., et al., Highly accurate protein structure prediction with AlphaFold. Nature, 2021. 596(7873): 583–589.
- Frappier, V., M. Chartier, and R.J. Najmanovich, ENCoM server: exploring protein conformational space and the effect of mutations on protein function and stability. Nucleic Acids Res, 2015. 43(W1): W395–400.
- Gerasimavicius, L., X. Liu, and J.A. Marsh, Identification of pathogenic missense mutations using protein stability predictors. Sci Rep, 2020. 10(1): 15387.
- Richards, S., et al., Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med, 2015. 17(5): 405–24.
- Tavtigian, S.V., et al., Fitting a naturally scaled point system to the ACMG/AMP variant classification guidelines. Hum Mutat, 2020. 41(10): 1734–1737.
- Liang, H., et al., A Chinese case of CHST3-related skeletal dysplasia and a systematic review. Endocrine, 2023. 80(3): 658–668.
- Bittles, A.H. and M.L. Black, Evolution in health and medicine Sackler colloquium: Consanguinity, human evolution, and complex diseases. Proc Natl Acad Sci U S A, 2010. 107 Suppl 1(Suppl 1): 1779–86.
- Richard, I., et al., Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell, 1995. 81(1): 27–40.
- Muys, J., et al., Prenatal homozygosity mapping detects a novel mutation in CHST3 in a fetus with skeletal dysplasia and joint dislocations. Clin Case Rep, 2017. 5(4): 440–445.
- Tanteles, G.A., et al., Two Somali half-siblings with CHST3-related chondrodysplasia illustrating the phenotypic spectrum and intrafamilial variability. Am J Med Genet A, 2013. 161A(10): 2588–93.
- Yan, W., et al., Novel carbohydrate sulfotransferase 3 mutation causing spondyloepiphyseal dysplasia with congenital joint dislocations in a Chinese family. . Ann Joint 2017. 2(2).
- Ranza, E., et al., Chondrodysplasia with multiple dislocations: comprehensive study of a series of 30 cases. Clin Genet, 2017. 91(6): 868–880.
- Van Biesen, N., P. Cools, and E. Meyers, Comparison and Optimization of DNA Extraction Methods for Human DNA from Dried Blood Spot Samples. Pediatr Rep, 2025. 17(2).
- Jarvik, G.P. and B.L. Browning, Consideration of Cosegregation in the Pathogenicity Classification of Genomic Variants. Am J Hum Genet, 2016. 98(6): 1077–1081.
DOI: https://doi.org/10.2478/ebtj-2026-0022 | Journal eISSN: 2564-615X
Language: English
Page range: 299 - 312
Published online: Oct 31, 2026
Published in print: Oct 1, 2026
Published by: European Biotechnology Thematic Network Association
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2026 Julia Vodopiutz, Magdalena Felderer, Gabriel Floriani, Dietmar Rieder, Dorota Garczarczyk-Asim, Thomas Müller, Andreas R Janecke, published by European Biotechnology Thematic Network Association
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.